These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 4215174)

  • 1. [The "in vitro" effect of gliclazide, a new hypoglycemic agent, on normal human blood platelets].
    Vainer H; Verry M
    Thromb Res; 1974 Apr; 4(4):523-38. PubMed ID: 4215174
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect of gliclazide on platelet behavior].
    Verry M; Dechavanne M; Desnoyers P; Stoltz JF; Vainer H
    Nouv Presse Med; 1974 Oct; 3(33):2099-100. PubMed ID: 4471584
    [No Abstract]   [Full Text] [Related]  

  • 3. Insulinotropic action of a new sulfonylurea: gliclazide.
    Malaisse WJ; Leclercq-Meyer V
    Rev Eur Etud Clin Biol; 1972 Mar; 17(3):310-4. PubMed ID: 4626523
    [No Abstract]   [Full Text] [Related]  

  • 4. [Diamicron].
    Journ Annu Diabetol Hotel Dieu; 1972; 13(0):343-9. PubMed ID: 4679568
    [No Abstract]   [Full Text] [Related]  

  • 5. [Long-term effect of gliclazide on platelet function in diabetes].
    Pan CY
    Zhonghua Yi Xue Za Zhi; 1984 Apr; 64(4):233-5. PubMed ID: 6432285
    [No Abstract]   [Full Text] [Related]  

  • 6. The effects of gliclazide on platelet function in patients with diabetes mellitus.
    Violi F; De Mattia GC; Alessandri C; Perrone A; Vezza E
    Curr Med Res Opin; 1982; 8(3):200-3. PubMed ID: 7128193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measure of platelet stickiness: the glass beads retention test in animal and human being.
    Desnoyers P; Verry M
    Acta Univ Carol Med Monogr; 1972; 53():381-9. PubMed ID: 4670743
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effect of the oral antidiabetic agent glibornuride on blood coagulation, blood platelets, and fibrinolysis].
    Voss D; Fuchs G; Schneider D; Schneider J
    Arzneimittelforschung; 1972 Dec; 22():Suppl 12A:2219. PubMed ID: 4679252
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of gliclazide on prostaglandin I2 formation in normal and streptozotocin-induced diabetic animals.
    Fujitani B; Maeda J; Tsuboi T; Kadokawa T; Shimizu M
    Jpn J Pharmacol; 1983 Oct; 33(5):965-70. PubMed ID: 6358588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The pharmacology S 1702, a new highly effective oral antidiabetic drug with unusual properties. 3. Antistickiness activity, fibrinolytic properties and haemostatic parameters study.
    Desnoyers P; Labaume J; Anstett M; Herrera M; Pesquet J; Sebastien J
    Arzneimittelforschung; 1972 Oct; 22(10):1691-5. PubMed ID: 4677058
    [No Abstract]   [Full Text] [Related]  

  • 11. Dynamics of insulin release and microtubular-microfilamentous system. IV. Effect of colchicine upon sulphonylurea-induced insulin secretion.
    Van Obberghen E; Devis G; Somers G; Ravazzola M; Malaisse-Lagae F; Malaisse WJ
    Eur J Clin Invest; 1974 Oct; 4(5):307-12. PubMed ID: 4426330
    [No Abstract]   [Full Text] [Related]  

  • 12. [Does hypoglycemic treatment with gliclazide and gliquidone affect platelet function in type II diabetic patients?].
    Strojek K; Bresler M; Gumprecht J; Grzeszczak W; Trautsolt W
    Pol Arch Med Wewn; 1993 Apr; 89(4):315-9. PubMed ID: 8351232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The pharmacology of S 1702, a new highly effective oral antibiabetic drug with unusual properties. 1. Pharmacological and hypoglycaemic activity, studies in different animal species.
    Duhault J; Boulanger M; Tisserand F; Bergi L
    Arzneimittelforschung; 1972 Oct; 22(10):1682-5. PubMed ID: 4677056
    [No Abstract]   [Full Text] [Related]  

  • 14. A clinical study of the metabolic effect of a new oral hypoglycemic agent: glipizide.
    Iacono G; Ghionni A; Colucci M; Verde G; Caputo G
    Int J Clin Pharmacol; 1974 Apr; 7(3):225-31. PubMed ID: 4850166
    [No Abstract]   [Full Text] [Related]  

  • 15. [The pharmacology of glisoxepide, a new oral antidiabetic].
    Puls W; Losert W; Loge O; Schillinger E; Keup U; Kroneberg G
    Arzneimittelforschung; 1974 Mar; 24(0):375-92. PubMed ID: 4408136
    [No Abstract]   [Full Text] [Related]  

  • 16. [Hypoglycemic agents of the 2d generation].
    Giulietti M
    Clin Ter; 1978 Jul; 86(2):179-81. PubMed ID: 743858
    [No Abstract]   [Full Text] [Related]  

  • 17. [Gliclazide, a new antidiabetic with hemobiologic and vascular properties].
    Plauchu M; Pousset G
    Lyon Med; 1972 Oct; 228(16):383-5. PubMed ID: 4637685
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of sulfonylurea agents on platelet arachidonic acid metabolism; study on platelet homogenates.
    Satoh K; Ozaki Y; Yatomi Y; Kume S
    Biochem Pharmacol; 1994 Aug; 48(5):1053-5. PubMed ID: 8093094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glypentide: a new hypoglycaemic agent.
    Morell J
    Biochem Pharmacol; 1974 Oct; 23(20):2922-4. PubMed ID: 4429592
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of oral hypoglycemic agents on platelet function.
    Papazafiropoulou A; Papanas N; Pappas S; Maltezos E; Mikhailidis DP
    J Diabetes Complications; 2015 Aug; 29(6):846-51. PubMed ID: 26026848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.